| Literature DB >> 26577692 |
Rickard P F Lindblom1, Birgitta Lytsy2, Camilla Sandström3, Nadjira Ligata3, Beata Larsson3, Ulrika Ransjö2, Christine Leo Swenne3,4.
Abstract
BACKGROUND: Coronary artery by-pass grafting (CABG) remains the optimal strategy in achieving complete revascularization in patients with complex coronary artery disease. However, sternal wound infections (SWI), especially deep SWI are potentially severe complications to the surgery. At the department of cardiothoracic surgery in Uppsala University Hospital a gradual increase in all types of SWI occurred, which peaked in 2009. This prompted an in-depth revision of the whole surgical process. To monitor the frequency of post-operative infections all patients receive a questionnaire that enquires whether any treatment for wound infection has been carried out.Entities:
Mesh:
Year: 2015 PMID: 26577692 PMCID: PMC4650278 DOI: 10.1186/s12872-015-0148-4
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Fig. 1Illustration of the inclusion process
Comparison between the population selected for detailed review with the whole study population (n = 1642)
| 2006–2012 | |||
|---|---|---|---|
| Review of patient medical records ( | No review of patient medical records ( |
| |
| Age (years) | 67 ± 9 | 67 ± 9 | 0.907 |
| Sex M/F | 410/93 | 923/241 | 0.874 |
Characteristics of the infected and non-infected groups (n = 503) seen over the whole study period
| Patients without infection ( | Patients with infections ( |
| |
|---|---|---|---|
| Patient related riskfactors | |||
| Age (years) | 67 ± 9 | 65 ± 10 |
|
| Sex M/F | 374/81 | 36/12 |
|
| Body mass index (kg/m2) | 28 ± 4 | 28 ± 4 |
|
| Preoperative insulin-like growth factor 1 (mmol/mol) | 45 ± 11 ( | 51 ± 17 ( |
|
| Diabetes (%) | 119/455 (26.5 %) | 20/48 (41.7 %) |
|
| Preoperative hemoglobin concentrations (g/L) | 141 ± 14 (451) | 137 ± 11 ( |
|
| Preoperative serum creatinine concentrations (μg/L) | 86 ± 28 ( | 85 ± 23 ( |
|
| Corticoid steroid treatment (%) | 12/455 (2.6 %) | 2/48 (4.2 %) |
|
| Current smoking no/smoked the last 2 months/never smoked | 54/314/87 | 7/36/5 |
|
| Chronic Obstructive Pulmonary Disease (%) | 12/455 (2.6 %) | 1/48 (2.1 %) |
|
| Ejection fraction (%) | 48 ± 9 ( | 49 ± 10 ( |
|
| Intraoperative risk factors | |||
| Number of saphenous vein grafts (n) | 3 ± 1 ( | 3 ± 1 |
|
| Internal mammary artery 0/1/2 | 41/412/2 | 2/46/0 |
|
| Duration of cardiopulmonary by-pass time (min) | 85 ± 29 ( | 85 ± 27 |
|
| Duration of aortic cross clamp time (min) | 47 ± 19 ( | 49 ± 19 |
|
| Postoperative risk factors | |||
| Erythrocyte transfusion day 0 (%) | 135/455 (29.7 %) | 19/48 (39.6 %) |
|
| Erythrocyte transfusion day 1 (%) | 71/455 (15.6 %) | 10/48 (20.1 %) |
|
| Erythrocyte transfusion day 2 (%) | 65/455 (14.3 %) | 14/48 (29.2 %) |
|
| Mean blood glucose concentration day 0 (mmol/L) | 7.8 ± 1.3 ( | 7.5 ± 1.0 |
|
| Mean blood glucose concentration day 1 (mmol/L) | 8.2 ± 1.6 ( | 8.5 ± 1.8 |
|
| Mean blood glucose concentration day 2 (mmol/L) | 9.0 ± 2.2 ( | 9.4 ± 3.0 ( |
|
*= p <0.05, **= p <0.01, **=p <0.001
Risk factors for self-reported sternal wound infection after coronary artery by-pass graft surgery in patients with review of medical records (n = 503), comparison between into period one and two
| 2006–2010 to week 26 (Period 1) | 2010 from week 27–2012 (Period 2) |
| |
|---|---|---|---|
|
|
| ||
| Patient related riskfactors | |||
| Age (years) | 67 ± 9 | 67 ± 9 |
|
| Sex M/F | 73/289 | 121/20 |
|
| Body mass index (kg/m2) | 28 ± 4 | 28 ± 4 |
|
| Preoperative insulin-like growth factor 1 (mmol/mol) | 46 ± 12 | 44 ± 11 |
|
| Diabetes (%) | 94/268 (26 %) | 45/96 (32 %) |
|
| Preoperative hemoglobin concentrations (g/L) | 140 ± 14 | 141 ± 14 |
|
| Preoperative serum creatinine concentrations (μg/L) | 86 ± 28 | 87 ± 38 |
|
| Chronic obstructive pulmonary disease (%) | 12/350 (3.3 %) | 1/140 (0.7 %) |
|
| Corticoid steroid treatment (%) | 6/356 (1.7 %) | 8/133 (5.7 %) |
|
| Current smoking/smoked the last 2 months/never smoked | 46/246/70 | 15/104/22 |
|
| Ejection fraction (%) | 48 ± 9 | 49 ± 8 |
|
| Intraoperative risk factors | |||
| Number of saphenous vein grafts (n) | 3 ± 1 | 3 ± 1 |
|
| Internal mammary artery 0/1/2 | 30/330/2 | 13/128/0 |
|
| Duration of cardiopulmonary by-pass time (min) | 85 ± 28 | 85 ± 29 |
|
| Duration of aortic cross clamp time (min) | 47 ± 19 | 48 ± 20 |
|
| Postoperative risk factors | |||
| Erythrocyte transfusion day 0 (%) | 118/244 (32.6 %) | 36/105 (25.5 %) |
|
| Erythrocyte transfusion day 1 (%) | 61/301 (16.9 %) | 20/121 (14.2 %) |
|
| Erythrocyte transfusion day 2 (%) | 66/296 (18.2 %) | 13/128 (9.2 %) |
|
| Mean blood glucose concentration day 0 (mmol/L) | 7.7 ± 1.3 | 8.2 ± 1.7 |
|
| Mean blood glucose concentration day 1 (mmol/L) | 8.2 ± 1.6 | 8.3 ± 1.8 |
|
| Mean blood glucose concentration day 2 (mmol/L) | 9.0 ± 2.3 | 8.9 ± 2.3 |
|
*= p <0.05, **= p <0.01, **=p <0.001
Risk factors for self-reported sternal wound infection after coronary artery by-pass graft surgery in patients with review of medical records (n = 503), comparison between into period one and two divided into infected and non-infected patients
| 2006–2010 to week 26 | 2010 from week 27–2012 | |||||
|---|---|---|---|---|---|---|
| Patients without infection ( | Patients with infections ( |
| Patients without infection ( | Patients with infections ( |
| |
| Patient related riskfactors | ||||||
| Age (years) | 67 ± 9 | 65 ± 10 |
| 68 ± 9 | 56 ± 7 |
|
| Sex M/F | 256/62 | 33/11 |
| 118/19 | 3/1 |
|
| Body mass index (kg/m2) | 28 ± 4 | 27.1 ± 4 |
| 28 ± 4 | 32 ± 4 |
|
| Preoperative insulin-like growth factor 1 (mmol/mol) | 46 ± 11 ( | 52 ± 18 ( |
| 44 ± 11 ( | 44 ± 8 |
|
| Diabetes (%) | 75/318 (23.6 %) | 19/44 |
| 44/137 (32.1 %) | 1/4 (25 %) |
|
| Preoperative hemoglobin concentrations (g/L) | 141 ± 14 ( | 137 ± 11 ( |
| 141 ± 14 ( | 136 ± 11 |
|
| Preoperative serum creatinine concentrations (μg/L) | 86 ± 22 ( | 86 ± 23 ( |
| 87 ± 39 | 70 ± 11 |
|
| Chronic obstructive pulmonary disease (%) | 11/318 (3.5 %) | 1/44 (2.3 %) |
| 1/137 (0.7 %) | 0/4 |
|
| Corticoid steroid treatment (%) | 5/318 (1.6 %) | 1/44 (2.3 %) |
| 7/137 (5.1 %) | 1/4 (25 %) |
|
| Current smoking/smoked the last 2 months/never smoked | 39/211 /68 | 7/35/2 |
| 15/103/19 | 0/1/3 |
|
| Ejection fraction (%) | 47 ± 10 ( | 49 ± 11 ( |
| 49 ± 8 ( | 51 ± 7 |
|
| Intra-operative risk factors | ||||||
| Number of saphenous vein grafts (n) | 3 ± 1 ( | 3 ± 1 |
| 3 ± 1 (107) | 4 ± 1 |
|
| Internal mammary artery 0/1/2 | 28/288/2 | 2/42/0 |
| 13/124/0 | 0/4/0 |
|
| Duration of cardiopulmonary by-pass time (min) | 84 ± 2 ( | 84 ± 28 |
| 85 ± 29 ( | 90 ± 6 |
|
| Duration of aortic cross clamp time (min) | 47 ± 18 ( | 48 ± 19 |
| 48 ± 20 ( | 53 ± 6 |
|
| Postoperative risk factors | ||||||
| Erythrocyte transfusion day 0 (%) | 100/318 (31.4 %) | 18/44 (40.9 %) |
| 35/137 (25.5 %) | 1/4 (25 %) |
|
| Erythrocyte transfusion day 1 (%) | 52/318 (16.4 %) | 9/44 (20.5 %) |
| 19/137 (13.9 %) | 1/4 (25 %) |
|
| Erythrocyte transfusion day 2 (%) | 53/318 (16.7 %) | 13/44 (29.5 %) |
| 12/137 (8.8 %) | 1/4 (25 %) |
|
| Mean blood glucose concentration day 0 (mmol/L) | 7.5 ± 1.1 ( | 7.5 ± 1.0 |
| 8.2 ± 1.7 ( | 7.6 ± 0.4 |
|
| Mean blood glucose concentration day 1 (mmol/L) | 8.1 ± 1.4 ( | 8.5 ± 1.9 |
| 8.3 ± 1.8 | 8.1 ± 0.9 |
|
| Mean blood glucose concentration day 2 (mmol/L) | 9.0 ± 2.1 ( | 9.4 ± 3.1 ( |
| 8.9 ± 2.4 ( | 9.1 ± 1.9 |
|
*= p <0.05, **= p <0.01, **=p <0.001